CAM vs. RE, AEP, MPE, CARR, ACRL, CDGP, KYGA, REVB, CBOX, and MCB
Should you be buying Camellia stock or one of its competitors? The main competitors of Camellia include R.E.A. (RE), Anglo-Eastern Plantations (AEP), M.P. Evans Group (MPE), Carr's Group (CARR), Accrol Group (ACRL), Chapel Down Group (CDGP), Kerry Group (KYGA), Revolution Beauty Group (REVB), Cake Box (CBOX), and McBride (MCB). These companies are all part of the "consumer defensive" sector.
R.E.A. (LON:RE) and Camellia (LON:CAM) are both small-cap consumer defensive companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, community ranking, analyst recommendations and institutional ownership.
48.9% of R.E.A. shares are held by institutional investors. Comparatively, 9.0% of Camellia shares are held by institutional investors. 71.1% of R.E.A. shares are held by insiders. Comparatively, 69.0% of Camellia shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
R.E.A. pays an annual dividend of GBX 8 per share and has a dividend yield of 9.8%. Camellia pays an annual dividend of GBX 146 per share and has a dividend yield of 3.3%. R.E.A. pays out -3,076.9% of its earnings in the form of a dividend. Camellia pays out -10,895.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Camellia received 47 more outperform votes than R.E.A. when rated by MarketBeat users. Likewise, 68.02% of users gave Camellia an outperform vote while only 64.81% of users gave R.E.A. an outperform vote.
In the previous week, R.E.A. had 4 more articles in the media than Camellia. MarketBeat recorded 5 mentions for R.E.A. and 1 mentions for Camellia. Camellia's average media sentiment score of 0.49 beat R.E.A.'s score of 0.17 indicating that R.E.A. is being referred to more favorably in the media.
Camellia has a net margin of -1.36% compared to Camellia's net margin of -5.80%. R.E.A.'s return on equity of -0.36% beat Camellia's return on equity.
R.E.A. has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500. Comparatively, Camellia has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500.
Camellia has higher revenue and earnings than R.E.A.. Camellia is trading at a lower price-to-earnings ratio than R.E.A., indicating that it is currently the more affordable of the two stocks.
Summary
R.E.A. beats Camellia on 9 of the 17 factors compared between the two stocks.
Get Camellia News Delivered to You Automatically
Sign up to receive the latest news and ratings for CAM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CAM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Camellia Competitors List
Related Companies and Tools